What is CureCare?
CureCare operates as a specialized healthcare services provider, focusing on the delivery of advanced infusion nursing. By partnering with specialty pharmacies, the company facilitates the administration of complex therapies directly to patients, prioritizing comfort and clinical efficacy. The firm distinguishes itself through a patient-centric model that enables therapy delivery in the patient's preferred environment, effectively decentralizing care from traditional clinical settings.
As one of the largest independent nursing providers in the specialty therapy infusion space, CureCare addresses the critical intersection of clinical compliance and patient satisfaction. Its market position is defined by a robust operational framework that ensures consistent, high-quality care for individuals managing acute or chronic conditions, thereby serving as a vital link in the specialty medication supply chain.
How much funding has CureCare raised?
CureCare has raised a total of $3K across 1 funding round:
Debt
$3K
Debt (2025): $3K with participation from Live Oak Bank
Key Investors in CureCare
Live Oak Bank
A specialized financial institution known for providing lending solutions and capital to small businesses and healthcare practices across the United States.
What's next for CureCare?
With the recent influx of capital, CureCare is expected to prioritize the expansion of its nursing network and the optimization of its digital patient management systems. The company's growth trajectory suggests a focus on deepening its partnerships with specialty pharmacies to broaden its geographic reach and service capacity. As the firm matures, the integration of advanced data analytics to monitor patient outcomes and therapy adherence will likely become a core component of its value proposition.
Furthermore, the transition toward Series A scaling indicates a strategic shift toward operational efficiency and market consolidation. By scaling its independent nursing model, CureCare aims to solidify its leadership in the infusion sector, potentially exploring new therapeutic areas that require high-touch, specialized nursing intervention. The company remains well-positioned to capitalize on the increasing demand for home-based and community-based specialty care.
